Clinical Trial Update: Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males [Phase 2]

View source ↗

Summary

Phase 2 trial update for a vaccine targeting HPV infection in young HIV-positive MSM; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Nonneoplastic Condition
• Penile Cancer
• Precancerous Condition

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Anal Cancer, Nonneoplastic Condition | Phase 2 | Status: COMPLETED | Results posted: 2020-05-27